Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: A prospective, longitudinal, controlled study

Journal of Clinical Oncology

Volumn 33, Issue 34, 2015, Pages 4085-4092

  Vardy, Janette L ^a,b,c   Dhillon, Haryana M ^a   Pond, Gregory R ^e   Rourke, Sean B ^d   Bekele, Tsegaye ^d   Renton, Corrinne ^a   Dodd, Anna ^c   Zhang, Haibo ^d   Beale, Philip ^b   Clarke, Stephen ^a   Tannock, Ian F ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Medical Oncology   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR; CAPECITABINE; CYTOKINE; FLUOROURACIL; OXALIPLATIN; SEX HORMONE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; ASSESSMENT OF HUMANS; ATTENTION; BLOOD EXAMINATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; COGNITION; COGNITIVE DEFECT; COLORECTAL CANCER; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; GENOTYPE; GLOBAL DEFICIT SCORE; HUMAN; LEARNING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT DURATION; VELOCITY; VERBAL MEMORY; WORKING MEMORY; CANCER STAGING; CASE CONTROL STUDY; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; LYMPH NODE METASTASIS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROGNOSIS; QUESTIONNAIRE; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; COLORECTAL NEOPLASMS; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84951747805     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.0905     Document Type: Article

References (23)

1. Ahles TA, Saykin AJ, McDonald BC, et al: Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110: 143-152, 2008
2. Schagen SB, Muller MJ, Boogerd W, et al: Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742-1745, 2006
3. Hermelink K, Untch M, Lux MP, et al: Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer 109:1905-1913, 2007
4. Wefel JS, Schagen SB: Chemotherapyrelated cognitive dysfunction. Curr Neurol Neurosci Rep 12:267-275, 2012
5. Vardy J, Rourke S, Tannock IF: Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. J Clin Oncol 25:2455-2463, 2007
6. Andreis F, Ferri M, Mazzocchi M, et al: Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients: A pilot study. Support Care Cancer 21:583-590, 2013
7. Cruzado JA, López-Santiago S, Martínez-Marín V, et al: Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Support Care Cancer 22: 1815-1823, 2014
8. Vardy J, Dhillon HM, Pond GR, et al: Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol 25:2404-2412, 2014
9. Yellen SB, Cella DF, Webster K, et al: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63-74, 1997
10. Cella D: The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:13-19, 1997
11. Wagner L, Sweet J, Butt Z, et al: Measuring patient self-reported cognitive function: Development of the Functional Assessment of Cancer Therapy-Cognitive Function instrument. J Support Oncol 7:W32-W39, 2009
12. Goldberg D, Williams P: A User's Guide to the General Health Questionnaire. Windsor, United Kingdom, NFER-Nelson, 1991
13. Carey CL, Woods SP, Rippeth JD, et al: Initial validation of a screening battery for the detection of HIV-Associated cognitive impairment. Clin Neuropsychol 18:234-248, 2004
14. Carey CL, Woods SP, Gonzalez R, et al: Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319, 2004
15. Wefel JS, Vardy J, Ahles T, et al: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703-708, 2011
16. Cysique LA, Franklin D Jr., Abramson I, et al: Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol 33:505-522, 2011
17. Sauerbrei W, Meier-Hirmer C, Benner A, et al: Multivariable regression model building by using fractional polynomials: Description of SAS, STATA, and R programs. Comput Stat Data An 50:3463-3485, 2006
18. Khan NF, Mant D, Carpenter L, et al: Longterm health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: A database study. Br J Cancer 105:S29-S37, 2011 (suppl 1)
19. Stouten-Kemperman MM, de Ruiter MB, Boogerd W, et al: Very late treatment-related alterations in brain function of breast cancer survivors. J Int Neuropsychol Soc 21:50-61, 2015
20. Ahles TA, Saykin AJ, McDonald BC, et al: Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. J Clin Oncol 28:4434-4440, 2010
21. Mandelblatt JS, Stern RA, Luta G, et al: Cognitive impairment in older patients with breast cancer before systemic therapy: Is there an interaction between cancer and comorbidity? J Clin Oncol 32: 1909-1918, 2014
22. Ahles TA, Saykin AJ, Noll WW, et al: The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612-619, 2003
23. Koleck TA, Bender CM, Sereika SM, et al: Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum 41:E313-E325, 2014